CANTERRA MINERALS CORP (CTM.CA) Fundamental Analysis & Valuation

TSX-V:CTM • CA1381342007

Current stock price

0.15 CAD
-0.01 (-3.23%)
Last:

This CTM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CTM.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CTM has reported negative net income.
  • CTM had a negative operating cash flow in the past year.
  • CTM had negative earnings in each of the past 5 years.
  • In the past 5 years CTM always reported negative operating cash flow.
CTM.CA Yearly Net Income VS EBIT VS OCF VS FCFCTM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

  • The Return On Assets of CTM (-25.61%) is comparable to the rest of the industry.
  • The Return On Equity of CTM (-27.69%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -25.61%
ROE -27.69%
ROIC N/A
ROA(3y)-30.77%
ROA(5y)-31.98%
ROE(3y)-36.11%
ROE(5y)-35.9%
ROIC(3y)N/A
ROIC(5y)N/A
CTM.CA Yearly ROA, ROE, ROICCTM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTM.CA Yearly Profit, Operating, Gross MarginsCTM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CTM.CA Health Analysis

2.1 Basic Checks

  • CTM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CTM has more shares outstanding
  • CTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTM.CA Yearly Shares OutstandingCTM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CTM.CA Yearly Total Debt VS Total AssetsCTM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • CTM has an Altman-Z score of 15.29. This indicates that CTM is financially healthy and has little risk of bankruptcy at the moment.
  • CTM has a better Altman-Z score (15.29) than 70.65% of its industry peers.
  • CTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.29
ROIC/WACCN/A
WACCN/A
CTM.CA Yearly LT Debt VS Equity VS FCFCTM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that CTM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.20, CTM is in line with its industry, outperforming 52.66% of the companies in the same industry.
  • A Quick Ratio of 2.20 indicates that CTM has no problem at all paying its short term obligations.
  • CTM has a Quick ratio (2.20) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2
CTM.CA Yearly Current Assets VS Current LiabilitesCTM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CTM.CA Growth Analysis

3.1 Past

  • CTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.90%.
EPS 1Y (TTM)-6.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CTM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTM.CA Price Earnings VS Forward Price EarningsCTM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTM.CA Per share dataCTM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CTM.CA Dividend Analysis

5.1 Amount

  • CTM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CTM.CA Fundamentals: All Metrics, Ratios and Statistics

CANTERRA MINERALS CORP

TSX-V:CTM (3/20/2026, 7:00:00 PM)

0.15

-0.01 (-3.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-02
Earnings (Next)04-23
Inst Owners0.92%
Inst Owner ChangeN/A
Ins Owners2.55%
Ins Owner ChangeN/A
Market Cap58.42M
Revenue(TTM)N/A
Net Income(TTM)-4.78M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.38
P/tB 3.38
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.61%
ROE -27.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.77%
ROA(5y)-31.98%
ROE(3y)-36.11%
ROE(5y)-35.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 15.29
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-91.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-201.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-201.41%
OCF growth 3YN/A
OCF growth 5YN/A

CANTERRA MINERALS CORP / CTM.CA Fundamental Analysis FAQ

What is the fundamental rating for CTM stock?

ChartMill assigns a fundamental rating of 2 / 10 to CTM.CA.


Can you provide the valuation status for CANTERRA MINERALS CORP?

ChartMill assigns a valuation rating of 0 / 10 to CANTERRA MINERALS CORP (CTM.CA). This can be considered as Overvalued.


What is the profitability of CTM stock?

CANTERRA MINERALS CORP (CTM.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for CTM stock?

The financial health rating of CANTERRA MINERALS CORP (CTM.CA) is 7 / 10.